Monica de Abadal

Senior Vice President, Head of Medical Affairs, North America

Monica de Abadal was appointed Senior Vice President, Head of Medical Affairs, North America in October 2021. As a key member of the North America Leadership Team and Chief Medical Officer Leadership Team, Monica is responsible for the strategic direction and leadership of our medical team as well as for planning, drug safety, and local medical affairs operations.

Monica has been with Ipsen since 2003 in several Medical Affairs roles with increasing responsibility. Most recently, she held the role of Vice President, Global Medical Excellence. Prior to that, she served as Vice President, Global Medical Affairs Services, Deputy CMO and Head of Publications. Monica has also served as the local Medical Director at Ipsen Australia. She is an experienced leader with a strong global background in transformation and leadership in Medical Affairs including Medical Strategy, Scientific Publications, Medical Communications, Medical Information, Clinical Operations, Medical Field excellence and Medical Governance. Monica currently serves as President of Europe and Middle East/Africa Region for the Medical Affairs Professional Society (MAPS).

Monica received her Medical Degree from Universitat Autònoma de Barcelona and a Master’s in Healthcare Administration from the University of San Francisco.

Our mission?

To improve patients’ lives

Acting on this mission has propelled us to become a global biopharmaceutical leader with a focus on innovation and specialty care. We help patients through our expertise in oncology, neuroscience, and rare disease.

Find out more about us or see other members of our leadership team.


Products and partnerships

Our products

Our mission is to improve patients’ lives.

See our products


Access our development and commercialization teams. We take bold steps to translate your science and innovations into solutions that make a difference for patients in need.

See more on partnering

Products and partnerships

What’s happening now?

See the latest
©2022 Ipsen Biopharmaceuticals, Inc. MP-US-000472 June 2022